ArticleNature neuroscience2026

The Alzheimer's therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia.

Giulia Albertini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.